biotech investing
The Struldbrug’s Curse: Why the Finance World Must Rethink Longevity Investing
Extending life without health is an economic curse. The real investment opportunity lies in the “healthspan revolution,” not just the longevity market.
High-Stakes Finance Unpacked: A PE Giant’s UK Nightmare, a Shadow Banking Mystery, and a Big Pharma Showdown
A deep dive into Cinven’s UK crisis, a fintech lending mystery involving a Utah bank, and Novo Nordisk’s strategic challenge to Pfizer.